Merck (Germany) Top Insiders
| MRK Stock | EUR 127.40 1.20 0.95% |
Merck employs about 62.3 K people. The company is managed by 42 executives with a total tenure of roughly 274 years, averaging almost 6.0 years of service per executive, having 1484.43 employees per reported executive. Examination of Merck's management performance can provide insight into the company performance.
| Kenneth Frazier Chairman Chairman of the Board, President, Chief Executive Officer |
| Jennifer Zachary President Executive Vice President, General Counsel, Corporate Secretary |
Merck |
Merck Management Team Effectiveness
The company has return on total asset (ROA) of 0.0528 % which means that it generated a profit of $0.0528 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1032 %, meaning that it generated $0.1032 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Merck's Intangible Assets are most likely to increase significantly in the upcoming years.Merck Quarterly Income Before Tax |
|
Shares in Circulation | First Issued 2016-12-31 | Previous Quarter 434.8 M | Current Value 434.8 M | Avarage Shares Outstanding 445.3 M | Quarterly Volatility 339.4 M |
Merck Workforce Comparison
Merck Company is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 102,571. Merck totals roughly 62,346 in number of employees claiming about 61% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. Merck Company Benchmark Summation
The output start index for this execution was one with a total number of output elements of sixty. The Lowest value over a specified period line plots minimum value of Merck Company price series.
Merck Notable Stakeholders
A Merck stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck often face trade-offs trying to please all of them. Merck's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kenneth Frazier | Chairman of the Board, President, Chief Executive Officer | Profile | |
| Jennifer Zachary | Executive Vice President, General Counsel, Corporate Secretary | Profile | |
| Julie Gerberding | Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health | Profile | |
| Rita Karachun | Senior Vice President - Finance, Global Controller | Profile | |
| Robert Davis | Executive Vice President, Global Services, Chief Financial Officer | Profile | |
| Michael Nally | Executive Vice President, Chief Marketing Officer | Profile | |
| Roger Perlmutter | Executive Vice President and Presidentident - Merck Research Laboratories | Profile | |
| Steven Mizell | Executive Vice President, Chief Human Resources Officer, Human Resources | Profile | |
| Sanat Chattopadhyay | Executive Vice President and President - Merck Manufacturing Division | Profile | |
| Richard DeLuca | Executive Vice President and Presidentident - Merck Animal Health | Profile | |
| Helene Roeder | CFO Board | Profile | |
| Thomas Glocer | Independent Director | Profile | |
| Christine Seidman | Independent Director | Profile | |
| Kathy Warden | Independent Director | Profile | |
| Paul Rothman | Independent Director | Profile | |
| Mary Coe | Independent Director | Profile | |
| Peter Wendell | Independent Director | Profile | |
| Leslie Brun | Lead Independent Director | Profile | |
| Inge Thulin | Independent Director | Profile | |
| Pamela Craig | Independent Director | Profile | |
| Patricia Russo | Independent Director | Profile | |
| Thomas Cech | Independent Director | Profile | |
| Matthias Heinzel | CEO Board | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Constantin Fest | Head Relations | Profile | |
| Khadija Hammada | Member Officer | Profile | |
| Jean Wirth | Member Science | Profile | |
| Michael Fleming | Senior Vice President Chief Ethics and Compliance Officer | Profile | |
| Peter Guenter | CEO Board | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Belen MD | Chair CEO | Profile | |
| Marcus Kuhnert | CFO Board | Profile | |
| Friederike Rotsch | Group Compliance | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Franklin Clyburn | Executive Vice President Chief Commercial Officer | Profile | |
| Dean Li | Executive Vice President and Presidentident, Merck Research Laboratories | Profile | |
| Kai Beckmann | Deputy Board | Profile | |
| Michael Heckmeier | Head Materials | Profile | |
| Frank Gotthardt | Head Europe | Profile | |
| Danny MD | Member Healthcare | Profile | |
| Marc Horn | Head Controlling | Profile | |
| Florian Schraeder | Head Relations | Profile |
About Merck Management Performance
The success or failure of an entity such as Merck Company often depends on how effective the management is. Merck management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.
Merck Workforce Analysis
Traditionally, organizations such as Merck use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck within its industry.Merck Manpower Efficiency
Return on Merck Manpower
| Revenue Per Employee | 339.3K | |
| Revenue Per Executive | 503.7M | |
| Net Income Per Employee | 44.5K | |
| Net Income Per Executive | 66.1M | |
| Working Capital Per Employee | 34.6K | |
| Working Capital Per Executive | 51.3M |
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |